Why the study?
Does the incidence and staining pattern of circulating anti-heart antibodies differ among patients with various heart diseases compared to healthy controls?
Does the incidence and staining pattern of circulating anti-heart antibodies differ among patients with various heart diseases compared to healthy controls?
Answers are grounded in this paper and cite their sources.
Circulating anti-heart antibodies and their specific immunofluorescent staining patterns are highly prevalent in certain heart diseases, particularly cardiomyopathies, suggesting a potential role in their pathogenesis.
Circulating anti-heart antibodies (C-AHAb) were examined in the sera of 132 patients with heart diseases and of 65 normal healthy controls using an indirect immunofluorescent technique. The patient groups consisted of 31 with dilated cardiomyopathy, 22 with hypertrophic cardiomyopathy, 38 with myocardial infarction, 15 with angina pectoris and 26 with rheumatic valvular disease. The indirect immunofluorescent staining patterns were classified into 4 types: "heterophile", "intracellular", "intercalated disc" and "nuclear" patterns. The positive incidence of C-AHAb was 81% in dilated cardiomyopathy, 77% in hypertrophic cardiomyopathy, 65% in rheumatic valvular disease, 58% in myocardial infarction, 40% in angina pectoris and 39% in normal healthy controls. A high rate of "heterophile" antibodies was found in the idiopathic cardiomyopathy group: 65% in dilated cardiomyopathy and 55% in hypertrophic cardiomyopathy. The intracellular staining pattern was present in 42% of rheumatic valvular disease. These findings suggest that positive C-AHAb and staining patterns may be useful in the assessment of the pathogenesis of certain types of heart diseases.
No takes yet. Share an insight, caveat, or question.
Yamakawa et al. (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: